We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Sep 20
The UK committee has resolved its investigations and recommended the MHRA that Covid-19 vaccine trials in the UK…
11 Sep 20
ENSPRYNG was recently approved by the US Food and Drug Administration (FDA) for adults with anti-aquaporin-4 (AQP4) antibody…
09 Sep 20
The UK-based drugmaker has voluntarily paused the clinical trials to ensure the review of safety data by an…
08 Sep 20
The clinical trial in Germany will evaluate the safety and efficacy of potential Covid-19 vaccine candidate BNT162b2 in…
04 Sep 20
Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing…
03 Sep 20
Janssen’s decision is based on results from the interim analyses of the Phase 3 clinical study of Pimodivir…
01 Sep 20
The Phase III D8110C00001 trial will evaluate the safety, efficacy and immunogenicity of the AZD1222 vaccine in up…
31 Aug 20
Farxiga is the first medicine to significantly prolong survival in a renal outcomes trial in patients with chronic…
24 Aug 20
Spartalizumab is an investigational monoclonal antibody under a development programme evaluating the immunotherapy across various tumour types
21 Aug 20
The new data showed that BNT162b2 administration was well tolerated across all populations, with mild to moderate fever…